ARVINAS, INC. — Director's Dealing 2022

Aug 16, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARVINAS, INC. (ARVN)
CIK: 0001655759
Period of Report: 2022-08-12

Reporting Person: Peck Ronald (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-12	Common Stock	M	4010	—	Acquired	9412	Direct
2022-08-12	Common Stock	S	1258	$68.994	Disposed	8154	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-08-12	Restricted Stock Units	$	M	4010	Disposed		Common Stock (4010.0)	Direct

Footnotes

F1: Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock.

F2: This sale was made to cover withholding taxes following the vesting of previously granted Restricted Stock Units.

F3: On July 29, 2019, the reporting person was granted 16,041 Restricted Stock Units, vesting in four equal annual installments beginning July 29, 2020.